Beech Tree Labs

Focus: Beech Tree Labs is a public-stage biotechnology company founded in 1998, headquartered in Providence, RI, focused on small molecules and biologics development across multiple therapeutic areas.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Beech Tree Labs

AI assessmentNot Hiring

No open roles listed right now. Follow Beech Tree Labs to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

BTL TML HSV

Oral Herpes Simplex

Phase 1/2

Clinical Trials (1)

NCT01308424Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

Phase 1/2

Help build intelligence for Beech Tree Labs

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established 26-year history with public status suggests operational maturity and stability relative to early-stage biotech.
Portfolio spanning small molecules and biologics modalities offers technical breadth for cross-functional skill development.
Active clinical pipeline with Phase 2 programs in viral infection and rare disease indications demonstrates ongoing R&D momentum.

Watch Out For

Zero current job openings and no hiring data suggests the company may not be actively scaling or may be in a consolidation phase.
No published financial metrics (revenue, R&D spend, cash position) raises transparency and stability questions for career planning.
Pipeline lacks Phase 3 programs; all programs are Phase 1/2, indicating early-stage risk and multi-year timelines to potential commercialization.

Generated by Claude from Beech Tree Labs's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

UISH001

Urinary Incontinence

Phase 1/2

Clinical Trials (1)

NCT01340066Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

Phase 1/2

BTL-TML-HSV

Oral Herpes Simplex

Phase 2

Clinical Trials (1)

NCT01902303Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores

Phase 2

BTL-TML-COVID

SARS-CoV-2 Infection

Phase 2

Clinical Trials (1)

NCT04522830A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 1998

Portfolio: 4 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo